Clinical Trial Update: MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for MEDITOXIN in subjects with post-stroke upper limb spasticity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Upper Limb Spasticity
• Spasticity of the Muscle

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Spasticity, Muscle | Phase 4 | Status: COMPLETED